Viewing Study NCT02340234


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-03-02 @ 6:24 PM
Study NCT ID: NCT02340234
Status: COMPLETED
Last Update Posted: 2017-10-02
First Post: 2015-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module